Overview

Detailed Summary

TCM Limited engages in solar panel trading and healthcare product manufacturing alongside solar panel installation and cattle feed production. Originally a chemical manufacturing company, TCM faced financial struggles leading to a shift in business focus.
In 2023, TCM updated its Memorandum of Association to include township development and infrastructure projects, showcasing diversification efforts.
TCM has recently established subsidiaries focusing on healthcare, property development, and solar projects, indicating a strategic shift towards new verticals.
Despite past financial challenges, the company is actively reviving operations with new business activities aligned with market opportunities.

Sector: Chemicals & Petrochemicals
Industry: Commodity Chemicals
Market Cap: 40 Cr
Volatility: Moderate Risk
P/E Ratio: -7.7
Industry P/E: 39.2
PEG Ratio: —
P/B Ratio: 1.6
52W High: 81.00
52W Low: 36.53

Sales CAGR

1Y: -24.11%
3Y: 34.04%
5Y: 32.31%
10Y: —

Profit CAGR

1Y: -527.86%
3Y: —
5Y: —
10Y: —

ROE

TTM: -23.53%
3Y: -0.26%
5Y: -4.14%
10Y: -2.89%

‌

Peers

Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
SHENTRA		119.15	53 Cr	-135.59	0.00	0.00	-3.13	6.40	-34.51
CAMEXLTD		51.44	52 Cr	-162.69	1.13	0.00	7.04	10.17	5.26
SHREYASI		6.11	44 Cr	-41.25	3.97	0.00	-8.33	-5.51	-4.29
TCMLMTD		55.05	40 Cr	-7.73	1.64	0.00	-23.53	-8.66	-6.35
HARLETH		56.40	28 Cr	23.93	0.62	1.75	5.30	8.02	2.25
SONALAD		42.95	26 Cr	22.44	2.51	0.00	14.62	10.75	2.37
ASINPET		10.72	26 Cr	26.09	1.99	0.00	9.33	10.80	2.38
Median: 7 Co.	—	51.44	40 Cr	-7.73	1.64	0.00	5.30	8.02	2.25

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total

QoQ

YoY

Total

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	8.59	5.28	6.90	6.18	7.65	3.21	5.92	5.69	4.92	4.88
Expenses	9.25	6.32	7.48	6.77	7.59	5.17	6.75	6.24	6.09	5.86
Operating Profit	-0.66	-1.04	-0.58	-0.59	0.06	-1.96	-0.83	-0.55	-1.17	-0.98
OPM %	-7.68	-19.70	-8.41	-9.55	0.78	-61.06	-14.02	-9.67	-23.78	-20.08
Other Income	0.34	0.04	0.03	0.06	4.34	0.06	0.60	0.09	0.21	0.06
Interest	0.02	0.00	0.00	0.28	0.31	0.39	0.50	0.54	0.50	0.52
Depreciation	0.10	0.08	0.08	0.09	0.10	0.10	0.11	0.17	0.18	0.16
Profit Before Tax	-0.43	-1.09	-0.64	-0.90	3.99	-2.39	-0.83	-1.18	-1.63	-1.60
Tax %	-9.30	0.00	0.00	0.00	-0.75	1.67	0.00	0.00	0.00	0.00
Net Profit	-0.47	-1.09	-0.64	-0.90	4.03	-2.35	-0.83	-1.18	-1.63	-1.60
EPS in Rs	-0.48	-1.31	-0.77	-1.16	5.39	-3.00	0.00	-1.53	-2.20	-21.40

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total

YoY

Total

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	0.40	0.92	4.25	3.55	7.35	32	26	20	21
Expenses	1.38	1.76	5.15	7.56	11	34	28	24	25
Operating Profit	-0.99	-0.84	-0.90	-4.01	-3.68	-2.24	-2.16	-4.51	-3.53
OPM %	-248.90	-91.07	-21.09	-112.76	-50.04	-6.96	-8.31	-22.83	-16.49
Other Income	0.04	1.15	1.23	-1.69	0.02	0.43	4.47	0.96	0.96
Interest	0.00	0.00	0.00	0.01	0.27	0.14	0.59	1.92	2.06
Depreciation	0.00	0.01	0.03	0.17	0.37	0.30	0.35	0.56	0.62
Profit Before Tax	-0.95	0.30	0.31	-5.88	-4.30	-2.25	1.37	-6.02	-5.24
Tax %	0.00	0.00	61.47	0.04	0.55	-1.76	-2.49	0.62	0.00
Net Profit	-0.95	0.30	0.12	-5.88	-4.27	-2.29	1.40	-5.99	-5.24
EPS in Rs	—	—	-0.37	-6.84	-5.41	-2.60	2.15	-6.73	-25.13
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total

YoY

Total

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	3.40	3.40	3.40	3.40	7.48	7.48	7.48	7.48
Reserves	29	29	29	22	23	21	23	17
Borrowings	5.38	5.64	5.83	6.53	1.44	0.27	11	22
Other Liabilities	31	27	29	30	37	55	35	36
Total Liabilities	69	65	68	61	69	84	76	83
Fixed Assets	58	58	59	55	36	17	8.96	9.05
CWIP	0.00	0.00	0.06	0.02	0.10	0.10	0.10	0.35
Investments	0.44	0.19	0.18	0.00	0.00	0.00	5.43	7.56
Other Assets	11	7.24	8.68	6.13	33	66	62	66
Total Assets	69	65	68	61	69	84	76	83

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total

YoY

Total

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-1.63	-0.57	0.39	-4.21	-11	1.95	-10	-5.22
Cash from Investing Activity	0.01	0.00	-0.51	4.22	5.84	-0.64	-0.18	-3.59
Cash from Financing Activity	5.32	-3.14	0.18	0.19	4.87	-1.30	10	9.02
Net Cash Flow	3.69	-3.70	0.06	0.20	-0.15	0.00	0.11	0.21

Shareholding History

Quarterly

Yearly

Quarterly

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	49.51%	49.51%	49.51%	49.51%	49.51%	49.51%	49.51%	49.51%	49.51%	49.51%	49.51%	49.51%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	7.71%	7.71%	7.71%	7.44%	7.44%	7.44%	7.44%	7.44%	7.44%	7.44%	7.44%	7.44%
Public	42.78%	42.78%	42.78%	43.05%	43.05%	43.05%	43.05%	43.05%	43.05%	43.05%	43.05%	43.05%
Total Shareholders	3,847	4,126	3,972	3,991	3,984	4,680	4,590	4,513	4,564	4,272	4,198	4,160

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

No documents found!

‌
‌

Partnership/JV

6 days ago

TCM Ltd enters JV MoU for Kalamassery villas

TCM Ltd signed a binding MoU on 2026-09-18 with Asset Homes Pvt Ltd and Mr. Suhas Nandan to form SPV 'Asset TCM Estates Pvt Ltd' to develop a premium residential villa project at Kalamassery, Ernakulam.

Frequently Asked Questions about TCM Ltd

TCM Ltd (TCMLMTD) is currently trading at 53.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

TCM Limited engages in solar panel trading and healthcare product manufacturing alongside solar panel installation and cattle feed production. Originally a chemical manufacturing company, TCM faced financial struggles leading to a shift in business focus. In 2023, TCM updated its Memorandum of Association to include township development and infrastructure projects, showcasing diversification efforts. TCM has recently established subsidiaries focusing on healthcare, property development, and solar projects, indicating a strategic shift towards new verticals. Despite past financial challenges, the company is actively reviving operations with new business activities aligned with market opportunities.

Over the past 52 weeks, TCM Ltd has traded between a low of ₹36.53 and a high of ₹81.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

TCM Ltd has a market capitalization of approximately 40.49. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

TCM Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -7.73 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 40.49 Cr, TCM Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

TCM Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of TCM Ltd is -7.73. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Tcm Ltd

Investor's Suite

Market Explorer

Market Pulse

Deep Dive

Utility

Company

Tcm Ltd

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison

Financial Statements